ENDEFR
Home › Germany › Dr. Falk Pharma GmbH

Dr. Falk Pharma GmbH

Gesellschaft mit beschränkter Haftung (GmbH) · Freiburg im Breisgau, Germany · LEI 529900443SK0GZ3LVE73
LEI activegroup parent

Summary

Dr. Falk Pharma GmbH is registered in Germany and entered in the “Commercial Register (Handelsregister)” under number HRB 3266. Its legal form is Gesellschaft mit beschränkter Haftung (GmbH) – private limited company (Germany). Dr. Falk Pharma GmbH is the ultimate parent of a group of 1 subsidiary in 1 country, as reported to GLEIF. GLEIF gives this reason: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus. It has 1 direct subsidiary in GLEIF data; 1 of them has a lapsed LEI. The LEI was first issued on 15 Jul 2015 and the record was last updated on 8 Jun 2026; the next renewal is due by 15 Jul 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formGesellschaft mit beschränkter Haftung (GmbH)
private limited company (Germany)
RegisterCommercial Register (Handelsregister) · Register website
Registration numberHRB 3266
Registration authorityLocal Court Freiburg
JurisdictionGermany
Registered addressLeinenweberstr. 5, 79108 Freiburg im Breisgau, Germany
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)30 Nov 1987
LEI529900443SK0GZ3LVE73
LEI statusactive
LEI first issued15 Jul 2015
LEI record last updated8 Jun 2026
Next LEI renewal15 Jul 2027
Corroboration of the LEI recordfully corroborated

Group membership

Dr. Falk Pharma GmbH this entity
Losan Pharma GmbH Germany lapsed

Parent not reported to GLEIF

  • Direct parent: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus.
  • Ultimate parent: the entity is controlled by one or more natural persons without an intermediate legal entity. GLEIF does not name them, and neither does AssetCensus.

Direct subsidiaries (1)